๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A randomized clinical trial of ursodeoxycholic acid as adjuvant treatment to prevent liver transplant rejection

โœ Scribed by D Barnes; D Talenti; G Cammell; M Goormastic; L Farquhar; M Henderson; D Vogt; J Mayes; MK Westveer; W Carey


Book ID
118686690
Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
175 KB
Volume
26
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


A randomized clinical trial of ursodeoxy
โœ D Barnes; D Talenti; G Cammell; M Goormastic; L Farquhar; M Henderson; D Vogt; J ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 174 KB ๐Ÿ‘ 2 views

Acute rejection following orthotopic liver transplantation is a common problem despite current immunosuppressive regimens. Ursodeoxycholic acid (UDCA) has been shown in small, open-labeled studies to prevent rejection episodes, although its effects on complications such as infections, length of hosp

A prospective, randomized, double-blind
โœ Fleckenstein, Jaquelyn F. ;Paredes, Melinda ;Thuluvath, Paul J. ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 68 KB ๐Ÿ‘ 1 views

Acute cellular rejection (ACR) after orthotopic liver transplantation occurs in 50% to 80% of patients despite the recent advances in immunosuppressive therapy. Adjuvant use of ursodeoxycholic acid (UDCA) is theoretically attractive, but studies have shown conflicting results. In this randomized, co

Ursodeoxycholic acid (UDCA) reduces hepa